1 World Health, O. Global tuberculosis report 2016. 142 p. (World Health Organization, 2016).
2 Gomes, T. et al. Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model. BMC Infect Dis14, 9, doi:10.1186/1471-2334-14-9 (2014).
3 Wilkinson, R. J. et al. Tuberculous meningitis. Nat Rev Neurol13, 581-598, doi:10.1038/nrneurol.2017.120 (2017).
4 Thwaites, G. E., van Toorn, R. & Schoeman, J. Tuberculous meningitis: more questions, still too few answers. The Lancet. Neurology12, 999-1010, doi:10.1016/s1474-4422(13)70168-6 (2013).
5 Schaller, M. A., Wicke, F., Foerch, C. & Weidauer, S. Central Nervous System Tuberculosis : Etiology, Clinical Manifestations and Neuroradiological Features. Clin Neuroradiol29, 3-18, doi:10.1007/s00062-018-0726-9 (2019).
6 Betjes, M. G. Hyponatremia in acute brain disease: the cerebral salt wasting syndrome. Eur J Intern Med13, 9-14, doi:10.1016/s0953-6205(01)00192-3 (2002).
7 Hannon, M. J. & Thompson, C. J. Hyponatremia in Neurosurgical Patients. Front Horm Res52, 143-160, doi:10.1159/000493244 (2019).
8 Donovan, J. et al. The neurocritical care of tuberculous meningitis. The Lancet. Neurology18, 771-783, doi:10.1016/s1474-4422(19)30154-1 (2019).
9 Misra, U. K., Kalita, J., Bhoi, S. K. & Singh, R. K. A study of hyponatremia in tuberculous meningitis. Journal of the neurological sciences367, 152-157 (2016).
10 Zheng, F. et al. Hyponatremia in Children With Bacterial Meningitis. Front Neurol10, 421, doi:10.3389/fneur.2019.00421 (2019).
11 Misra, U. K., Kalita, J. & Consortium, T. M. I. R. Mechanism, spectrum, consequences and management of hyponatremia in tuberculous meningitis. Wellcome Open Research4, 189 (2019).
12 Spasovski, G. et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med40, 320-331, doi:10.1007/s00134-014-3210-2 (2014).
13 Thao, L. T. P. et al. Prognostic Models for 9-Month Mortality in Tuberculous Meningitis. Clin Infect Dis66, 523-532, doi:10.1093/cid/cix849 (2018).
14 Rock, R. B., Olin, M., Baker, C. A., Molitor, T. W. & Peterson, P. K. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev21, 243-261, table of contents, doi:10.1128/cmr.00042-07 (2008).
15 Sütlaş, P. N., Unal, A., Forta, H., Senol, S. & Kirbaş, D. Tuberculous meningitis in adults: review of 61 cases. Infection31, 387-391, doi:10.1007/s15010-003-3179-1 (2003).
16 Moghtaderi, A., Alavi-Naini, R., Izadi, S. & Cuevas, L. E. Diagnostic risk factors to differentiate tuberculous and acute bacterial meningitis. Scand J Infect Dis41, 188-194, doi:10.1080/00365540902721384 (2009).
17 Thwaites, G. E. et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet360, 1287-1292, doi:10.1016/s0140-6736(02)11318-3 (2002).
18 Thakur, R., Goyal, R. & Sarma, S. Laboratory diagnosis of tuberculous meningitis - is there a scope for further improvement? J Lab Physicians2, 21-24, doi:10.4103/0974-2727.66705 (2010).
19 Kim, S. H. et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Infect Dis50, 1349-1358, doi:10.1086/652142 (2010).
20 Ropper, A. H., Raymond D. Adams, Maurice Victor, Robert H. Brown, and Maurice Victor. Adams and Victor's principles of neurology. (New York: McGraw-Hill Medical Pub. Division, 2005).
21 Thwaites, G. et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect59, 167-187, doi:10.1016/j.jinf.2009.06.011 (2009).
22 Lee, H. & Kim, T. Rapid Development of Intracranial Aneurysm Associated with Tuberculous Meningitis. Can J Neurol Sci44, 730-731, doi:10.1017/cjn.2017.229 (2017).
23 Sinha, M. K. et al. Vision impairment in tuberculous meningitis: predictors and prognosis. Journal of the neurological sciences290, 27-32, doi:10.1016/j.jns.2009.12.012 (2010).
24 Yoon, J. H. et al. Incidence and risk factors of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation in adults with prophylactic ursodiol and intravenous heparin or prostaglandin E1. Bone Marrow Transplant, doi:10.1038/s41409-021-01215-y (2021).